Trial · NCT01782326
Participant flow22
How many started, completed or left each group, period by period.
1 to 20 of 22
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Planned Treatment Epoch | STARTED | QVA149 | 1,680 | |
| Planned Treatment Epoch | STARTED | Long Acting B2 Agonist (LABA) and Inhaled Corticosteroid (ICS) | 1,682 | |
| Planned Treatment Epoch | Full Analysis Set (FAS) | QVA149 | 1,675 | |
| Planned Treatment Epoch | Full Analysis Set (FAS) | Long Acting B2 Agonist (LABA) and Inhaled Corticosteroid (ICS) | 1,679 | |
| Planned Treatment Epoch | Per-protocol Set (PPS) | QVA149 | 1,528 | |
| Planned Treatment Epoch | Per-protocol Set (PPS) | Long Acting B2 Agonist (LABA) and Inhaled Corticosteroid (ICS) | 1,556 | |
| Planned Treatment Epoch | Serial Spirometry Set | QVA149 | 280 | |
| Planned Treatment Epoch | Serial Spirometry Set | Long Acting B2 Agonist (LABA) and Inhaled Corticosteroid (ICS) | 279 | |
| Planned Treatment Epoch | Safety Set (SAF) | QVA149 | 1,678 | |
| Planned Treatment Epoch | Safety Set (SAF) | Long Acting B2 Agonist (LABA) and Inhaled Corticosteroid (ICS) | 1,680 | |
| Planned Treatment Epoch | Urine Cortisol Set | QVA149 | 266 | |
| Planned Treatment Epoch | Urine Cortisol Set | Long Acting B2 Agonist (LABA) and Inhaled Corticosteroid (ICS) | 269 | |
| Planned Treatment Epoch | COMPLETED | QVA149 | 1,478 | |
| Planned Treatment Epoch | COMPLETED | Long Acting B2 Agonist (LABA) and Inhaled Corticosteroid (ICS) | 1,474 | |
| Planned Treatment Epoch | NOT COMPLETED | QVA149 | 202 | |
| Planned Treatment Epoch | NOT COMPLETED | Long Acting B2 Agonist (LABA) and Inhaled Corticosteroid (ICS) | 208 | |
| Double-blind Treatment | STARTED | QVA149 | 1,678 | |
| Double-blind Treatment | STARTED | Long Acting B2 Agonist (LABA) and Inhaled Corticosteroid (ICS) | 1,680 | |
| Double-blind Treatment | COMPLETED | QVA149 | 1,400 | |
| Double-blind Treatment | COMPLETED | Long Acting B2 Agonist (LABA) and Inhaled Corticosteroid (ICS) | 1,360 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01782326/flow